Associated Papers
Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter Trial.
Park S et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 2025
Potential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial.
Chiu J et al.
Bmc Medicine, 2023
Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis.
Tabata J et al.
Cancer Research, 2022
36166639 (PubMed )
Supplement: can-22-0834_supplementary_table_s1_suppst1.xlsx › Supplementary_Table_S1
Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy.
Ramos-Paradas J et al.
Journal of Clinical Medicine, 2022
35329826 (PubMed )
Supplement: jcm-11-01500-s001.zip › J_Ramos-Paradas_et_al.__Table_S2.xlsx › Molecular_alterations_TST170
Genetic screening for Bartter syndrome and Gitelman syndrome pathogenic genes among individuals with hypertension and hypokalemia.
Bao M et al.
Clinical and Experimental Hypertension (new York, N.y. : 1993), 2019
29953267 (PubMed )
Supplement: supplement_1.pdf
APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas.
Kojima Y et al.
Surgery Today, 2018
Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy.
Sugimachi K et al.
British Journal of Cancer, 2018
Select a paper to view details